Exscientia to receive 15M in milestones for Sanofi collaboration Exscientia plc achieves milestones in collaboration with Sanofi, receiving 15M in payments and potential future milestone payments of over 600M.

Exscientia to receive 15M in milestones for Sanofi collaboration

Under 67% of Exscientia's investor base is looking to short. The analysis of current outlook of investing in Exscientia Ltd ADR suggests that many traders are alarmed regarding Exscientia's prospects. Exscientia's investing sentiment shows overall attitude of investors towards Exscientia Ltd ADR.
  
Exscientia plc achieves milestones in collaboration with Sanofi, receiving 15M in payments and potential future milestone payments of over 600M.

Read at seekingalpha.com
seekingalpha News
  

Exscientia Fundamental Analysis

We analyze Exscientia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exscientia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exscientia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

Exscientia is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Exscientia ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Exscientia stock to make a market-neutral strategy. Peer analysis of Exscientia could also be used in its relative valuation, which is a method of valuing Exscientia by comparing valuation metrics with similar companies.

Peers

Exscientia Related Equities

UBXUnity Biotechnology   4.04   
0%
61.0%
LPTXLeap Therapeutics   2.78   
0%
42.0%
AVIRAtea Pharmaceuticals   1.42   
0%
21.0%
RXRXRecursion Pharmaceuticals   1.22   
0%
18.0%
GLUEMonte Rosa   1.00   
0%
15.0%
ZURAZura Bio   0.97   
0%
14.0%
ELEVElevation Oncology   0.31   
0%
4.0%
MREOMereo BioPharma   0.87   
13.0%
0%
BPMCBlueprint Medicines   2.58   
39.0%
0%
PDSBPDS Biotechnology   3.68   
56.0%
0%
KYMRKymera Therapeutics   4.04   
61.0%
0%
RVMDRevolution Medicines   4.13   
62.0%
0%
SANASana Biotechnology   4.31   
65.0%
0%
IPSCCentury Therapeutics   5.00   
76.0%
0%
ADAPAdaptimmune Therapeutics   5.38   
82.0%
0%
RLAYRelay Therapeutics   6.56   
100.0%
0%
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Exscientia Stock

If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bonds Directory
Find actively traded corporate debentures issued by US companies
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas